FENOFIBRIC ACID - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for fenofibric acid and what is the scope of freedom to operate?
Fenofibric acid
is the generic ingredient in one branded drug marketed by Athena and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.There are four drug master file entries for fenofibric acid.
Summary for FENOFIBRIC ACID
US Patents: | 4 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Drug Master File Entries: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 115 |
Clinical Trials: | 21 |
Patent Applications: | 2,889 |
Drug Prices: | Drug price trends for FENOFIBRIC ACID |
What excipients (inactive ingredients) are in FENOFIBRIC ACID? | FENOFIBRIC ACID excipients list |
DailyMed Link: | FENOFIBRIC ACID at DailyMed |
Recent Clinical Trials for FENOFIBRIC ACID
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Chong Kun Dang Pharmaceutical | Phase 1 |
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Federal University of São Paulo | Phase 4 |
US Patents and Regulatory Information for FENOFIBRIC ACID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Athena | FIBRICOR | fenofibric acid | TABLET;ORAL | 022418-002 | Aug 14, 2009 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Athena | FIBRICOR | fenofibric acid | TABLET;ORAL | 022418-002 | Aug 14, 2009 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Athena | FIBRICOR | fenofibric acid | TABLET;ORAL | 022418-001 | Aug 14, 2009 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |